General discussion, page-286

First 286 Last

Share
Profile

Follow
Exalted

1,869 Posts.

1472

16/05/20

13:07

Post #: 44655450
Share

Originally posted by andres: ↑

Hi Dalts - it would be highly unusual in my experience for a Company to telegraph what strategy they may employ post trials. I think they would evaluate it on a product by product basis. For example, they may license, sell off, spin out, manufacture, merge - any number of possibilities and also depending on whether it is the Apnea, ARDS, concussion etc.... health solution. Also noting that a lot depends on third party players, margins, global distribution etc... One thing I can say, the IHL Board are very savvy Corporate guys and are heavily invested in maximum return.

Just to describe the supply chain, Valens is an OEM. They are B to B and do not retail but manufacture for others. Cannvalate is a prescriber and they don't produce any products. They dispense. The actual product brand is what is sold - as in Incannex for IHL products. As I said, it wouldn't surprise me that they would use them as the primary source of supply/manufacture.

Expand

Nailed it Andres.

Currently IHL supplier is Linnea SA iirc, from Switzerland.

Valens is Canadian and if the costs work out in our favor I wouldn't be surprised to see IHL switch to Valens instead.

IHL Price at posting: 5.2¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

There are more pages in this discussion • 3,948 more messages in this thread...

First 286 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

General discussion, page-286

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Monash IVF shares cater 25% – Disaster or deep-value play?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Featured News